Moody Aldrich Partners’s Protagonist Therapeutics PTGX Stock Holding History

Moody Aldrich Partners’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.31M	Buy	59,601 +5,708	+11%	+$596K	1.31%	11
2026 Q1	$5.68M	Sell	53,893 -26,730	-33%	-$2.37M	1.02%	31
2025 Q4	$7.04M	Sell	80,623 -62,437	-44%	-$5.11M	1.31%	13
2025 Q3	$9.5M	Sell	143,060 -27,510	-16%	-$1.56M	1.8%	3
2025 Q2	$9.43M	Buy	170,570 +7,087	+4%	+$340K	1.82%	2
2025 Q1	$7.91M	Buy	163,483 +96,068	+143%	+$4.03M	1.66%	12
2024 Q4	$2.6M	Sell	67,415 -51,872	-43%	-$2.26M	0.48%	81
2024 Q3	$5.37M	Sell	119,287 -14,928	-11%	-$603K	0.98%	41
2024 Q2	$4.65M	Buy	134,215 +33,696	+34%	+$987K	0.91%	47
2024 Q1	$2.91M	Buy	100,519 +38,192	+61%	+$1.04M	0.49%	81
2023 Q4	$1.43M	Sell	62,327 -6,641	-10%	-$116K	0.26%	109
2023 Q3	$1.15M	Buy	68,968 +27,108	+65%	+$526K	0.22%	113
2023 Q2	$1.16M	Buy	+41,860	New	+$1.05M	0.22%	114

Other funds holding PTGX

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Moody Aldrich Partners's PTGX Position: Q2 2026 in Review

Moody Aldrich Partners increased its Protagonist Therapeutics (PTGX) stake by 11% in Q2 2026, buying an estimated $596K and bringing the position to 59,601 shares worth $7.31M. The position accounts for 1.31% of the portfolio, ranked #11.

Moody Aldrich Partners first reported a position in PTGX in Q2 2023 and has held it in 13 quarters since. The position peaked at $9.5M in Q3 2025. 40 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

Moody Aldrich Partners held 59,601 shares of Protagonist Therapeutics worth $7.31M as of Q2 2026.
Moody Aldrich Partners bought 5,708 Protagonist Therapeutics shares in Q2 2026, an estimated $596K.
Protagonist Therapeutics made up 1.31% of Moody Aldrich Partners's portfolio in Q2 2026, its #11 holding.
Moody Aldrich Partners first reported a position in Protagonist Therapeutics in Q2 2023 and has held it in 13 quarters since.
Moody Aldrich Partners's Protagonist Therapeutics position peaked at $9.5M in Q3 2025.
40 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.